Akari Therapeutics, Plc (AKTX) Stock Price

0.8075 ▲ +0.0525 (+6.95%)
Open: 0.686 Vol: 0 Day's range: 0.682 - 0.8252 Sep 17, 15:53 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.81▼ 0.78▲ 0.78▲ 0.78▲ 0.82▼
MA10 0.80▲ 0.78▲ 0.79▲ 0.79▲ 0.94▼
MA20 0.77▲ 0.75▲ 0.74▲ 0.81▼ 1.08▼
MA50 0.72▲ 0.81▼ 0.84▼ 0.96▼ 1.28▼
MA100 0.87▼ 0.96▼ 1.00▼ 1.12▼ 2.00▼
MA200 1.09▼ 1.14▼ 1.13▼ 1.13▼ 8.14▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.006▲ 0.013▲ 0.016▲ 0.009▲ -0.016▼
RSI 58.728▲ 54.690▲ 53.822▲ 44.562▼ 35.587▼
STOCH 87.445▲ 54.898     57.750     59.749     25.064    
WILL %R -12.360▲ -23.289▲ -23.289▲ -25.708     -65.136    
CCI 56.414     71.975     81.808     1.989     -115.460▼
Latest Filters Detected On AKTX
MA $AKTX Price Crossed Above MA(13) Set Alert
MA $AKTX Price Crossed Above MA(7) Set Alert
▼ GAP $AKTX Open Gap Down %5 Set Alert
▼ GAP $AKTX Open Gap Down %3 Set Alert
▼ GAP $AKTX Open Gap Down %2 Set Alert
CDL $AKTX Engulfing Candlestick Pattern Detected Set Alert
Akari Therapeutics, Plc News
Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
Wednesday, September 17, 2025 05:55 AM
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed a provisional patent application ...
Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Thursday, September 04, 2025 11:45 PM
BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today ...
Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Wednesday, September 03, 2025 05:42 AM
As part of the event, Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics will provide a corporate overview and discuss its innovative payload platform fueling a pipeline ...
AKTX historical stock data
date open high low close volume
17/09/25 0.686 0.8252 0.682 0.8075 3,364,484
16/09/25 0.7755 0.80 0.7535 0.755 43,421
15/09/25 0.80 0.80 0.761 0.7755 15,037
12/09/25 0.77 0.80 0.7511 0.789 25,690
11/09/25 0.77 0.7882 0.7555 0.77 109,721
10/09/25 0.8398 0.8759 0.7756 0.79 153,183
09/09/25 0.8859 0.8892 0.8319 0.8401 36,990
08/09/25 0.83 0.85 0.80 0.85 75,611
05/09/25 0.6998 0.8188 0.6901 0.8187 70,966
04/09/25 0.678 0.7499 0.6601 0.73 109,291
Quote Details
52wk Low:0.571
52wk High:3.85
Vol:0
Avg Vol(3m):2.1M
1Y Chng:-73.08%
1M Chng:-18.02%
Add to Watch List
More Information
Index US Composite
Market Cap. 25.73M